Patrik Schatz1,2,3, Dror Sharon4, Sermed Al-Hamdani5,6, Sten Andréasson7, Michael Larsen5,6,8. 1. Department of Ophthalmology, Clinical Sciences, Scane County University Hospital, University of Lund, 22185, Lund, Sweden. patrik.schatz@med.lu.se. 2. Department of Ophthalmology, Glostrup Hospital, Glostrup, Denmark. patrik.schatz@med.lu.se. 3. National Eye Clinic, Kennedy Center, Glostrup, Denmark. patrik.schatz@med.lu.se. 4. Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 5. Department of Ophthalmology, Glostrup Hospital, Glostrup, Denmark. 6. National Eye Clinic, Kennedy Center, Glostrup, Denmark. 7. Department of Ophthalmology, Clinical Sciences, Scane County University Hospital, University of Lund, 22185, Lund, Sweden. 8. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
PURPOSE: Our aim was to analyze retinal structure in young patients with Best disease with reference to future gene therapy. METHODS: This was a retrospective observational spectral domain optical coherence tomography study of four patients aged 10 years or less with Best disease. RESULTS: Findings ranged from subtle thickening at the level of the retinal pigment epithelium-photoreceptor interdigitation line, to subretinal fluid and precipitate-like changes at the level of the photoreceptor outer segments, and further to choroidal neovascularization. The photoreceptor inner segment ellipsoid layer could be visualized seemingly undisturbed above the vitelliform lesions, except in the case of choroidal neovascularization. CONCLUSIONS: Clinical variability is evident even among young patients aged 10 years or less with Best disease. The earliest structural alterations seem to occur at the level of the retinal pigment epithelium-photoreceptor interdigitation line. The photoreceptor inner segment seems to be unaffected unless choroidal neovascularization develops, which seems promising regarding future gene therapy.
PURPOSE: Our aim was to analyze retinal structure in young patients with Best disease with reference to future gene therapy. METHODS: This was a retrospective observational spectral domain optical coherence tomography study of four patients aged 10 years or less with Best disease. RESULTS: Findings ranged from subtle thickening at the level of the retinal pigment epithelium-photoreceptor interdigitation line, to subretinal fluid and precipitate-like changes at the level of the photoreceptor outer segments, and further to choroidal neovascularization. The photoreceptor inner segment ellipsoid layer could be visualized seemingly undisturbed above the vitelliform lesions, except in the case of choroidal neovascularization. CONCLUSIONS: Clinical variability is evident even among young patients aged 10 years or less with Best disease. The earliest structural alterations seem to occur at the level of the retinal pigment epithelium-photoreceptor interdigitation line. The photoreceptor inner segment seems to be unaffected unless choroidal neovascularization develops, which seems promising regarding future gene therapy.
Authors: K Petrukhin; M J Koisti; B Bakall; W Li; G Xie; T Marknell; O Sandgren; K Forsman; G Holmgren; S Andreasson; M Vujic; A A Bergen; V McGarty-Dugan; D Figueroa; C P Austin; M L Metzker; C T Caskey; C Wadelius Journal: Nat Genet Date: 1998-07 Impact factor: 38.330
Authors: R Burgess; R E MacLaren; A E Davidson; J E Urquhart; G E Holder; A G Robson; A T Moore; R O' Keefe; G C M Black; F D C Manson Journal: J Med Genet Date: 2008-07-08 Impact factor: 6.318
Authors: Rosemary Burgess; Ian D Millar; Bart P Leroy; Jill E Urquhart; Ian M Fearon; Elfrida De Baere; Peter D Brown; Anthony G Robson; Genevieve A Wright; Philippe Kestelyn; Graham E Holder; Andrew R Webster; Forbes D C Manson; Graeme C M Black Journal: Am J Hum Genet Date: 2008-01 Impact factor: 11.025
Authors: Gaël Manes; Isabelle Meunier; Almudena Avila-Fernández; Sandro Banfi; Guylène Le Meur; Xavier Zanlonghi; Marta Corton; Francesca Simonelli; Philippe Brabet; Gilles Labesse; Isabelle Audo; Saddek Mohand-Said; Christina Zeitz; José-Alain Sahel; Michel Weber; Hélène Dollfus; Claire-Marie Dhaenens; Delphine Allorge; Elfride De Baere; Robert K Koenekoop; Susanne Kohl; Frans P M Cremers; Joe G Hollyfield; Audrey Sénéchal; Maxime Hebrard; Béatrice Bocquet; Carmen Ayuso García; Christian P Hamel Journal: Am J Hum Genet Date: 2013-08-29 Impact factor: 11.025